Phase 3 trials comparing high-dose therapy (HDT) with conventional chemotherapy (Chemo) as frontline therapy for multiple myeloma
V indicates vincristine; M, melphalan; C, cyclophosphamide; P, prednisone; B, carmustine; and A, Adriamycin.
Sign In or Create an Account